Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3192313 | Annals of Allergy, Asthma & Immunology | 2010 | 10 Pages |
Abstract
In patients with PAR and RDS, mometasone furoate NS use improved nasal symptoms, sleepiness, and impairment in daily activities. Correlated reduced nasal symptoms and improved performance suggest that improving AR symptoms with mometasone furoate NS administration can benefit sleep and daytime functioning.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Eli O. MD, Dominic A. MD, Weiyuan MS, Gokul MD, Santosh T. MD,